Skip to main content
. 2019 May 7;18:59. doi: 10.1186/s12933-019-0856-7

Fig. 3.

Fig. 3

Estimate of difference from baseline in systolic blood pressure (SBP) at Week 26 by subgroup. Data are presented as n1, n2, and n3 where n1 = number of patients in the placebo group, n2 = number of patients in the ertugliflozin 5 mg group, and n3 = number of patients in the ertugliflozin 15 mg group. BMI body mass index, eGFR estimated glomerular filtration rate, HbA1c glycated hemoglobin